I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Sarabia de Ardanaz, Luis
;
Andreu Ubero, José María
;
Navidad Fuentes, Miriam
...
Sarabia De Ardanaz L. [et al.] (2021) Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment. Front. Pharmacol. 12:620187. doi: [10.3389/fphar.2021.620187]. , 2021
Link:
http://hdl.handle.net/10481/70202
RT Journal T1 <Title>Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftunivgranada:oai:digibug.ugr.es:10481_70202&Exemplar=1&LAN=DE A1 Sarabia de Ardanaz, Luis A1 Andreu Ubero, José María A1 Navidad Fuentes, Miriam A1 Ferrer González, Miguel Ángel A1 Ruiz del Valle, Víctor A1 Salcedo Bellido, Inmaculada A1 Barrios Rodríguez, Rocío A1 Cáliz Cáliz, Antonio Rafael A1 Requena Méndez, María del Pilar PB Frontiers Research Foundation YR 2021 K1 COVID-19 K1 Immunosupression K1 Tocilizumab K1 Mortality K1 Risk factor K1 Platelet JF Sarabia De Ardanaz L. [et al.] (2021) Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment. Front. Pharmacol. 12:620187. doi: [10.3389/fphar.2021.620187] LK http://hdl.handle.net/10481/70202 DO http://hdl.handle.net/10481/70202 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
